These are glimpses into the work we do, the things we care about, and the milestones we’re working towards.

World Health Organization (WHO) Publishes Global Report on Psoriasis

The report aims to raise awareness of psoriasis and fight negative perceptions of people living with disease. The complexity of the disease requires a more holistic “whole person” approach to care.

Our Cambridge Research Center Opens in Cambridge, Massachusetts

A 43,000-square-foot research center in the Cambridge, Massachusetts, biotech corridor will be devoted to neurodegenerative diseases such as Alzheimer’s.

Expanding Our Cystic Fibrosis Collaboration with Galapagos

The cystic fibrosis (CF) combination therapy we are developing with Galapagos is on track. Following successful completion of Phase 2 development, AbbVie will be responsible for Phase 3.

First Quarter 2016 Financial Results

We believe 2016 is off to an exceptional start, with double-digit sales and adjusted earnings growth in the first quarter. Read the full news release.

Five Things to Know on World Parkinson’s Day

World Parkinson’s Day is observed annually on April 11 to raise awareness of the disease, promoting a greater understanding of the condition and how it can affect a person. Learn more about the disease, how many people are impacted, treatment and more.

Cystic Fibrosis Patients Beat Odds and Follow Their Dreams

Today, students with cystic fibrosis (CF) are living longer and conquering high school, college and even graduate school. AbbVie is proud to assist them through our CF Scholarship program.

AbbVie Foundation Website Shines Light on Needs of Underserved

The AbbVie Foundation recently launched a new website to shine a light on the needs of the underserved around the world and highlight the high-impact work the Foundation supports through its partners.

2015 Financial Results

A strong 2015 saw our revenue grow 15 percent, delivering adjusted earnings-per-share of $4.29, up 29 percent from a year ago, and generating momentum we expect to build upon in 2016.

Remarkable 2015 for patients, top 5 reasons why

Our third year as AbbVie is drawing to a close. As we look back, it’s been an incredible year on many fronts, with successes in the laboratory, in manufacturing, in our commercial operations and behind the scenes, where our work to solidify our foundation as a stand-alone biopharmaceutical company has firmly taken root.

Spreading smart care across europe

Early intervention is one remedy for sustaining healthcare systems in Europe. The first installment of “Smart Care: Sustainable Health For The Future,” a new Euronews series, features our efforts to help Spanish patients with joint, muscle and back pain get back to work.